We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
-2.56%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.1M
AUM Growth
-$4.11M
Cap. Flow
-$36.3K
Cap. Flow %
-0.04%
Top 10 Hldgs %
52.17%
Holding
55
New
2
Increased
23
Reduced
20
Closed
5

Top Buys

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$3.69M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$2.44M
3
GVA icon
Granite Construction
GVA
+$2.37M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$1.25M
5
PLCE icon
Children's Place
PLCE
+$882K

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$4.78M
2
ABM icon
ABM Industries
ABM
+$1.95M
3
EGHT icon
8x8 Inc
EGHT
+$1.43M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$1.37M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.31M

Sector Composition

Rank Sector Weight
1 Industrials 23.04%
2 Financials 19.17%
3 Healthcare 16.6%
4 Consumer Staples 10.26%
5 Technology 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTI icon
1
Universal Technical Institute
UTI
$1.98B
$7.86M 8.53%
2,292,487
– –
GIFI
2
DELISTED
Gulf Island Fabrication
GIFI
$5.14M 5.57%
723,407
-3,000
-0.4% -$24.7K
ABCB icon
3
Ameris Bancorp
ABCB
$6.05B
$4.91M 5.33%
125,341
+2,772
+2% +$101K
GVA icon
4
Granite Construction
GVA
$5.5B
$4.72M 5.12%
97,970
+54,246
+124% +$2.37M
AIMT
5
DELISTED
Aimmune Therapeutics
AIMT
$4.62M 5.02%
222,117
+4,387
+2% +$90.3K
PNFP icon
6
Pinnacle Financial Partners Inc
PNFP
$14.7B
$4.61M 5%
80,135
– –
PRAH
7
DELISTED
PRA Health Sciences, Inc.
PRAH
$4.61M 5%
46,465
+38,621
+492% +$3.69M
ICPT
8
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.12M 4.48%
51,832
+1,231
+2% +$110K
GVP
9
DELISTED
GSE Systems, Inc.
GVP
$3.88M 4.21%
165,882
-1,586
-0.9% -$39K
ISBC
10
DELISTED
Investors Bancorp, Inc.
ISBC
$3.6M 3.91%
323,246
+7,143
+2% +$80.9K
SYNH
11
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$3.57M 3.88%
69,977
+52,498
+300% +$2.44M
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$3.55M 3.85%
120,230
+18,419
+18% +$710K
HOMB icon
13
Home BancShares
HOMB
$6.09B
$3.16M 3.42%
163,839
– –
MDGL icon
14
Madrigal Pharmaceuticals
MDGL
$12.4B
$2.01M 2.18%
19,162
-12,194
-39% -$1.31M
PLCE icon
15
Children's Place
PLCE
$60.3M
$1.87M 2.03%
19,610
+8,636
+79% +$882K
PCH
16
DELISTED
PotlatchDeltic
PCH
$1.65M 1.79%
42,358
-308
-0.7% -$11.6K
EFOR
17
Everforth Inc
EFOR
$836M
$1.61M 1.75%
26,538
-3,750
-12% -$225K
PSMT icon
18
Pricesmart
PSMT
$5.74B
$1.59M 1.72%
31,039
+15,372
+98% +$858K
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.42M 1.54%
58,902
-17,546
-23% -$445K
KNX icon
20
Knight Transportation
KNX
$12.4B
$1.41M 1.53%
42,845
+19,318
+82% +$617K
NTB icon
21
Bank of N.T. Butterfield & Son
NTB
$2.4B
$1.38M 1.5%
40,720
-290
-0.7% -$10.7K
ZWS icon
22
Zurn Elkay Water Solutions
ZWS
$7.92B
$1.36M 1.47%
+93,183
New +$1.25M
HIL
23
DELISTED
Hill International, Inc. Common Stock
HIL
$1.33M 1.44%
491,070
-174,933
-26% -$462K
MMS icon
24
Maximus
MMS
$3.02B
$1.13M 1.23%
15,586
+5,732
+58% +$416K
SAGE
25
DELISTED
Sage Therapeutics
SAGE
$971K 1.05%
5,307
-28,023
-84% -$4.78M
1
2 3

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Pacific View Asset Management held 55 positions worth $92.1M, down 4.3% from $96.3M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pacific View Asset Management's Q2 2019 filing shows 2 new, 23 increased, 20 reduced and 5 closed positions. Its largest new stake was Zurn Elkay Water Solutions: 93,183 shares worth $1.36M. The largest sale was Sage Therapeutics, an estimated $4.78M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Pacific View Asset Management's largest Q2 2019 buy was Zurn Elkay Water Solutions: 93,183 shares worth $1.36M.
  • Pacific View Asset Management added most to PRA Health Sciences, Inc. in Q2 2019, an estimated $3.69M increase.
  • Pacific View Asset Management's biggest Q2 2019 reduction was Sage Therapeutics, cutting an estimated $4.78M.
  • Pacific View Asset Management fully exited Axsome Therapeutics in Q2 2019, selling an estimated $568K.
  • Pacific View Asset Management's ten largest holdings make up 52% of its $92.1M portfolio in Q2 2019.
  • Pacific View Asset Management opened 2 new positions and closed 5 in Q2 2019.
  • Pacific View Asset Management's portfolio value fell 4.3% quarter-over-quarter to $92.1M.

Based on Pacific View Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.